PYMADIN

Welcome to the Brand page for “PYMADIN”, which is offered here for Pharmaceutical preparation for treatment of peripheral neuritis and neuralgia and treatment of neurological disorders including multiple sclerosis, myasthenia gravis, congenital myasthenia, eaton-lampert syndrome, spinal cord injury, verapamil overdose, alzheimer's disease and botulism;.

Its status is currently believed to be active. Its class is unavailable. “PYMADIN” is believed to be currently owned by “SOPHARMA USA CORPORATION”.

Owner:
SOPHARMA USA CORPORATION
Owner Details
Description:
Pharmaceutical preparation for treatment of peripheral neuritis and neuralgia and treatment of neurological disorders including multiple sclerosis, myasthenia gravis, congenital myasthenia, eaton-lampert syndrome, spinal cord injury, verapamil overdose, alzheimer's disease and botulism;
Categories: PHARMACEUTICAL PREPARATION TREATMENT